{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"5q-minus","columns":[{"gene":"","key":"population-499f0b1609fc261dda5e","label":"Chromosome 5q deletion syndrome","mondoId":"MONDO:0007925","onsetQualifier":null,"originColumnKey":"MONDO:0007925/OMIM:153550","originalViews":[{"key":"MONDO:0007925/OMIM:153550","label":"Chromosome 5q deletion syndrome","scopeLabel":"OMIM:153550","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["265b8345c4e575cb43b465d3c723cf2901e98c330738964335cb58ebf27964b2","42dd33c0c985ae97d64b8820bf75479b90a718deeff45fc5c77084237287ed2c","4d781e5635d1f7be20386625db5b21a06dfe0b713a95d74ede4df09e0dfb0fca","68d4560171afcb88140ee216376167e4f7dc22850d6a281563441b4139fc078c","b29f059e573601810551e0ad2a3ee124ed020850bcdb72bbc495b053b7771baf"],"recordQualifiers":{},"scopeLabel":"OMIM:153550","sourceIds":["OMIM:153550"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-d4772d5d0d4972ee2edb","label":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","mondoId":"MONDO:0007925","onsetQualifier":null,"originColumnKey":"MONDO:0007925/ORPHA:86841","originalViews":[{"key":"MONDO:0007925/ORPHA:86841","label":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","scopeLabel":"ORPHA:86841","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["078c6699be81ed0f6aa35e7af18e8bd9c4987242188cb532e2fa5ab42daa9249","238ec526697bbaf42dd00a21140d8821929eb7b1ac8fb1ee8cb0a8e83a5f1ec8","36303b43f8b5ecfd04417b05c512ae86222dfac398319faf4b803e177e8bfa5c","3b785a59988bcb5fd98d2129b6456fb1fdb3f78d06fef90f884a5fca21568b6e","3eec2cd6b6908a7395583ee807c790952f297336a24fc693a9eef80550ee6991","43f2b3cd27af99954af5a74696a55154f87f990e000cb6e38a2872da211da686","6334a79101ea03858901a6ad5db04da0ae6f7ac174a5414bcdf6c8e663fd079f","6d28d7ce92daeefcff9d3b99820bc6f4d7c4a991a5dc0a8f6b465115bf8debd9","7d89acc7a0c07c879da5f3d8887d2de377e3349a7097d0bc255236b9162a5628","8da11abb8b752085d6da7313120fe5f34ee33d69619a92dec2cd3270ade6b23f","a5dbb17297160bc2957baf2378555c58867afe8a568b7a62ed63029bdf2f90dd","b8c596c4a24c81c53e1bf3313252703fc7ce8b226f197e0c0d2dffbd886aa842","cd310dc12c476a93add88198ed69dc8cb7ae94c3812a8d1b168d7539eee3881d","d5869320a872e4025b8d03a30c3995bdc2e427cb03bde639dfd204bb8d726f3c","dc80a0407084e9c2c524b9ae554815456f42aa6a6d1d4dae49ee311b97f9a4a5","dfa026604f03c14770db3f659cd0aed2bdb21cee2f30db45f24ec59986843cc4","f248aa67dd29d6eb1276a626b1dff85d57365127a40b97037f117e354b676135","f2634468d2200db98ab418ca312a694f05ebee734697c839d0c416e5b9ce48d4"],"recordQualifiers":{},"scopeLabel":"ORPHA:86841","sourceIds":["ORPHA:86841"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-499f0b1609fc261dda5e","population-d4772d5d0d4972ee2edb"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001892","HP:0001877","HP:0012143","HP:0011992","HP:0012129","HP:0004808","HP:0010972"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":23,"sourceGroups":{"omim":1,"orphanet":18,"published":4}},"features":[{"hpoId":"HP:0001892","label":"Abnormal bleeding","primary":true},{"hpoId":"HP:0001877","label":"Abnormal erythrocyte morphology","primary":true},{"hpoId":"HP:0012143","label":"Abnormal megakaryocyte morphology","primary":true},{"hpoId":"HP:0011992","label":"Abnormal neutrophil morphology","primary":true},{"hpoId":"HP:0012129","label":"Abnormality of bone marrow stromal cells","primary":true},{"hpoId":"HP:0004808","label":"Acute myeloid leukemia","primary":true},{"hpoId":"HP:0010972","label":"Anemia of inadequate production","primary":true},{"hpoId":"HP:0011273","label":"Anisocytosis","primary":false},{"hpoId":"HP:0031020","label":"Bone marrow hypercellularity","primary":false},{"hpoId":"HP:0005528","label":"Bone marrow hypocellularity","primary":false},{"hpoId":"HP:0031035","label":"Chronic infection","primary":false},{"hpoId":"HP:0001882","label":"Decreased total leukocyte count","primary":false},{"hpoId":"HP:0012133","label":"Erythroid hypoplasia","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0001972","label":"Macrocytic anemia","primary":false},{"hpoId":"HP:0031385","label":"Megakaryocyte nucleus hypolobulation","primary":false},{"hpoId":"HP:0012148","label":"Multiple lineage myelodysplasia","primary":false},{"hpoId":"HP:0002863","label":"Myelodysplasia","primary":false},{"hpoId":"HP:0004861","label":"Refractory macrocytic anemia","primary":false},{"hpoId":"HP:0001894","label":"Thrombocytosis","primary":false}],"ledeHtml":"5q minus (5q-) syndrome is a type of bone marrow disorder called myelodysplastic syndrome (MDS). MDS comprises a group of conditions in which immature blood cells fail to develop normally, resulting in too many immature cells and too few normal mature blood cells. In 5q- syndrome, development of red blood cells is particularly affected, leading to a shortage of these cells (anemia). In addition, the red blood cells that are present are unusually large (macrocytic). Although many people with 5q- syndrome have no symptoms related to anemia, especially in the early stages of the condition, some affected individuals develop extreme tiredness (fatigue), weakness, and an abnormally pale appearance (pallor) as the condition worsens. Individuals with 5q- syndrome also have abnormal development of bone marrow cells called megakaryocytes, which produce platelets, the cells involved in blood clotting. A common finding in people with 5q- syndrome is abnormal cells described as hypolobated megakaryocytes. In addition, some individuals with 5q- syndrome have an excess of platelets, while others have normal numbers of platelets. MDS is considered a slow-growing (chronic) blood cancer. It can progress to a fast-growing blood cancer called acute myeloid leukemia (AML). Progression to AML occurs less commonly in people with 5q- syndrome than in those with other forms of MDS.","mondoId":"MONDO:0007925","node":{"canonicalSlug":"5q-minus","comparisons":[{"documentSha256":"b91db95264cef5fd4f24f1dc216759d230fcd9611f9931c6d8be06258446497b","key":"legacy-5q-minus","kind":"legacy","label":"myelodysplastic syndrome associated with isolated del(5q)","memberIds":["MONDO:0007925"],"mondoId":"MONDO:0007925","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/5q-minus.b91db95264cef5fd4f24f1dc216759d230fcd9611f9931c6d8be06258446497b.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Myelodysplastic syndrome associated with isolated del(5q)","originalSourceId":"ORPHA:86841","paragraphs":["5q minus (5q-) syndrome is a type of bone marrow disorder called myelodysplastic syndrome (MDS). MDS comprises a group of conditions in which immature blood cells fail to develop normally, resulting in too many immature cells and too few normal mature blood cells. In 5q- syndrome, development of red blood cells is particularly affected, leading to a shortage of these cells (anemia). In addition, the red blood cells that are present are unusually large (macrocytic). Although many people with 5q- syndrome have no symptoms related to anemia, especially in the early stages of the condition, some affected individuals develop extreme tiredness (fatigue), weakness, and an abnormally pale appearance (pallor) as the condition worsens. Individuals with 5q- syndrome also have abnormal development of bone marrow cells called megakaryocytes, which produce platelets, the cells involved in blood clotting. A common finding in people with 5q- syndrome is abnormal cells described as hypolobated megakaryocytes. In addition, some individuals with 5q- syndrome have an excess of platelets, while others have normal numbers of platelets. MDS is considered a slow-growing (chronic) blood cancer. It can progress to a fast-growing blood cancer called acute myeloid leukemia (AML). Progression to AML occurs less commonly in people with 5q- syndrome than in those with other forms of MDS."],"rawAttribution":"MONDO:0007925","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:24Z","upstream":"MONDO:0007925","url":"https://rarediseases.info.nih.gov/diseases/8723"},"ownColumnKeys":["population-499f0b1609fc261dda5e","population-d4772d5d0d4972ee2edb"],"publication":"published","relationships":[{"kind":"parent","label":"macrocytic anemia","mondoId":"MONDO:0002281","slug":null},{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null},{"kind":"parent","label":"partial deletion of the long arm of chromosome 5","mondoId":"MONDO:0016904","slug":null},{"kind":"parent","label":"myelodysplastic syndrome","mondoId":"MONDO:0018881","slug":"myelodysplastic"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/5q-minus-syndrome"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"078c6699be81ed0f6aa35e7af18e8bd9c4987242188cb532e2fa5ab42daa9249","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011273","is_excluded":false,"label":"Anisocytosis","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"238ec526697bbaf42dd00a21140d8821929eb7b1ac8fb1ee8cb0a8e83a5f1ec8","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001882","is_excluded":false,"label":"Decreased total leukocyte count","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"265b8345c4e575cb43b465d3c723cf2901e98c330738964335cb58ebf27964b2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:153550","disease_name":"Chromosome 5q deletion syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012133","is_excluded":false,"label":"Erythroid hypoplasia","onset_id":null,"reference":"PMID:7949083","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"36303b43f8b5ecfd04417b05c512ae86222dfac398319faf4b803e177e8bfa5c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005528","is_excluded":false,"label":"Bone marrow hypocellularity","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b785a59988bcb5fd98d2129b6456fb1fdb3f78d06fef90f884a5fca21568b6e","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001892","is_excluded":false,"label":"Abnormal bleeding","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3eec2cd6b6908a7395583ee807c790952f297336a24fc693a9eef80550ee6991","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004808","is_excluded":false,"label":"Acute myeloid leukemia","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"42dd33c0c985ae97d64b8820bf75479b90a718deeff45fc5c77084237287ed2c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:153550","disease_name":"Chromosome 5q deletion syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031385","is_excluded":false,"label":"Megakaryocyte nucleus hypolobulation","onset_id":null,"reference":"PMID:7949083","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"43f2b3cd27af99954af5a74696a55154f87f990e000cb6e38a2872da211da686","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031020","is_excluded":false,"label":"Bone marrow hypercellularity","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4d781e5635d1f7be20386625db5b21a06dfe0b713a95d74ede4df09e0dfb0fca","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:153550","disease_name":"Chromosome 5q deletion syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004861","is_excluded":false,"label":"Refractory macrocytic anemia","onset_id":null,"reference":"PMID:7949083","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"6334a79101ea03858901a6ad5db04da0ae6f7ac174a5414bcdf6c8e663fd079f","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001877","is_excluded":false,"label":"Abnormal erythrocyte morphology","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"68d4560171afcb88140ee216376167e4f7dc22850d6a281563441b4139fc078c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:153550","disease_name":"Chromosome 5q deletion syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002863","is_excluded":false,"label":"Myelodysplasia","onset_id":null,"reference":"OMIM:153550","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6d28d7ce92daeefcff9d3b99820bc6f4d7c4a991a5dc0a8f6b465115bf8debd9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7d89acc7a0c07c879da5f3d8887d2de377e3349a7097d0bc255236b9162a5628","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001972","is_excluded":false,"label":"Macrocytic anemia","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8da11abb8b752085d6da7313120fe5f34ee33d69619a92dec2cd3270ade6b23f","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012148","is_excluded":false,"label":"Multiple lineage myelodysplasia","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a5dbb17297160bc2957baf2378555c58867afe8a568b7a62ed63029bdf2f90dd","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012143","is_excluded":false,"label":"Abnormal megakaryocyte morphology","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b29f059e573601810551e0ad2a3ee124ed020850bcdb72bbc495b053b7771baf","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:153550","disease_name":"Chromosome 5q deletion syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0010972","is_excluded":false,"label":"Anemia of inadequate production","onset_id":null,"reference":"PMID:7949083","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b8c596c4a24c81c53e1bf3313252703fc7ce8b226f197e0c0d2dffbd886aa842","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012133","is_excluded":false,"label":"Erythroid hypoplasia","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd310dc12c476a93add88198ed69dc8cb7ae94c3812a8d1b168d7539eee3881d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012129","is_excluded":false,"label":"Abnormality of bone marrow stromal cells","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d5869320a872e4025b8d03a30c3995bdc2e427cb03bde639dfd204bb8d726f3c","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002863","is_excluded":false,"label":"Myelodysplasia","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dc80a0407084e9c2c524b9ae554815456f42aa6a6d1d4dae49ee311b97f9a4a5","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031385","is_excluded":false,"label":"Megakaryocyte nucleus hypolobulation","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dfa026604f03c14770db3f659cd0aed2bdb21cee2f30db45f24ec59986843cc4","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031035","is_excluded":false,"label":"Chronic infection","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f248aa67dd29d6eb1276a626b1dff85d57365127a40b97037f117e354b676135","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001894","is_excluded":false,"label":"Thrombocytosis","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f2634468d2200db98ab418ca312a694f05ebee734697c839d0c416e5b9ce48d4","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:86841","disease_name":"Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011992","is_excluded":false,"label":"Abnormal neutrophil morphology","onset_id":null,"reference":"ORPHA:86841","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8723\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007925\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0007925</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>5q minus (5q-) syndrome is a type of bone marrow disorder called myelodysplastic syndrome (MDS). MDS comprises a group of conditions in which immature blood cells fail to develop normally, resulting in too many immature cells and too few normal mature blood cells. In 5q- syndrome, development of red blood cells is particularly affected, leading to a shortage of these cells (anemia). In addition, the red blood cells that are present are unusually large (macrocytic). Although many people with 5q- syndrome have no symptoms related to anemia, especially in the early stages of the condition, some affected individuals develop extreme tiredness (fatigue), weakness, and an abnormally pale appearance (pallor) as the condition worsens. Individuals with 5q- syndrome also have abnormal development of bone marrow cells called megakaryocytes, which produce platelets, the cells involved in blood clotting. A common finding in people with 5q- syndrome is abnormal cells described as hypolobated megakaryocytes. In addition, some individuals with 5q- syndrome have an excess of platelets, while others have normal numbers of platelets. MDS is considered a slow-growing (chronic) blood cancer. It can progress to a fast-growing blood cancer called acute myeloid leukemia (AML). Progression to AML occurs less commonly in people with 5q- syndrome than in those with other forms of MDS.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8723\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"5q-minus","sourceDocuments":[{"name":"GARD: Myelodysplastic syndrome associated with isolated del(5q)","reviewed":null,"source_release":"2026-10-21T17:06:24Z","url":"https://rarediseases.info.nih.gov/diseases/8723"},{"name":"MONDO: myelodysplastic syndrome associated with isolated del(5q)","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007925"}],"sourceNote":"","synonyms":["5q deletion syndrome","5Q minus syndrome","5q syndrome","5Q- syndrome","5q- syndrome","5q- syndrome, refractory macrocytic anaemia due to 5q deletion","chromosome 5q deletion syndrome","macrocytic anemia, refractory, due to 5q deletion, somatic","MAR","myelodysplastic syndrome associated with isolated del (5q) chromosome Abnormality","myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality","myelodysplastic syndrome with 5q deletion","myelodysplastic syndrome with isolated del(5q)","refractory macrocytic anaemia due to 5q deletion","refractory macrocytic anemia due to 5q deletion"],"takeawayHtml":"","title":"myelodysplastic syndrome associated with isolated del(5q)"},"schemaVersion":1}
